The present invention relates to the use of a compound of formula (I) in the treatment of a warm-blooded animal target of VEGF-dependent angiogenic disease, a method of using said compound in the treatment of said disease in warm-blooded animals, especially humans, and treatment of said disease To a pharmaceutical composition comprising said compound for use, and said compound for use in the treatment of said disease. [Chemical formula 5] [Selected figure] None本発明は、ＶＥＧＦ依存性血管新生疾患の温血動物標的の治療における、式（Ｉ）の化合物の使用、温血動物、特にヒトの前記疾患の治療における前記化合物の使用方法、前記疾患を治療するための、前記化合物を含む医薬組成物、および前記疾患の治療に使用するための前記化合物に関する。【化５】【選択図】 なし
